SCHEMBL6468046

SCHEMBL6468046

Cc1cc(S(=O)(=O)c2ccc(F)cc2)ccc1-n1cc(NC(N)=O)c(C(N)=O)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.43
CFTR P13569 4/20 0.39
KIF11 P52732 1/20 0.36
NR3C2 P08235 1/20 0.35
MAPT P10636 3/20 0.35
RXFP1 Q9HBX9 1/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
HTR6 P50406 2/20 0.34
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
KCNH2 Q12809 1/20 0.33
IKBKB O14920 1/20 0.33
ABCC9 O60706 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507064 0.90 ITK (0.43) ITKCFTRKIF11ALDH1A1CA12
SCHEMBL6506387 0.88 ITK (0.41) ITKCFTRKIF11NR3C2MAPT
SCHEMBL6468270 0.84 CA9 (0.48) ITKCFTRMAPTKDM4EALDH1A1
SCHEMBL6470399 0.82 ITK (0.44) ITKNR3C2MAPTKDM4EALDH1A1
SCHEMBL6507544 0.82 NAMPT (0.41) ITKCFTRMAPTRXFP1ALDH1A1
SCHEMBL6470265 0.78 ITK (0.42) ITKMAPTKDM4ECA12CA1
SCHEMBL6467613 0.78 ITK (0.49) ITKKDM4EHTTKCNH2
SCHEMBL6506696 0.76 ITK (0.56) ITKNR3C2MAPTPOLBKDM4E
SCHEMBL6469876 0.76 HSD11B1 (0.42) ITKCFTRMAPTKDM4EALDH1A1
SCHEMBL6467527 0.75 KDM4E (0.47) ITKMAPTPOLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885CFTR 2359/4885KIF11 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.